Gene · 7045
Papers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,774
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Management of Stromal Corneal Dystrophies; Review of the Literature with a Focus on Phototherapeutic Keratectomy and Keratoplasty. | Vision (Basel) | 2023 | 36977302 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 | 36973268 | PubTator, text mining | PubMed |
| Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction. | CNS Neurosci Ther | 2023 | 36971196 | PubTator, text mining | PubMed |
| Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis. | Front Genet | 2023 | 36968610 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals underlying host responses in pediatric respiratory syncytial virus pneumonia. | iScience | 2023 | 36968072 | PubTator, text mining | PubMed |
| Spatiotemporal Characterization of Human Early Intervertebral Disc Formation at Single-Cell Resolution. | Adv Sci (Weinh) | 2023 | 36965031 | PubTator, text mining | PubMed |
| Exosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia report. | Ann N Y Acad Sci | 2023 | 36961472 | PubTator, text mining | PubMed |
Identification of diagnostic markers related to oxidative stress and inflammatory response in diabetic kidney disease by machine learning algorithms: Evidence from human transcriptomic data and mouse experiments. | Front Endocrinol (Lausanne) | 2023 | 36960398 | PubTator, text mining | PubMed |
| SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma. | BMC Urol | 2023 | 36959648 | PubTator, text mining | PubMed |
Expression of inflammatory, angiogenic, and extracellular matrix-related mediators in the cervicovaginal fluid of women with preterm premature rupture of membranes: Relationship with acute histological chorioamnionitis. | Am J Reprod Immunol | 2023 | 36950805 | PubTator, text mining | PubMed |
| Extracellular vesicles in osteoarthritis of peripheral joint and temporomandibular joint. | Front Endocrinol (Lausanne) | 2023 | 36950682 | PubTator, text mining | PubMed |
| Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers. | Mol Cancer | 2023 | 36941614 | PubTator, text mining | PubMed |
| Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. | Heliyon | 2023 | 36938461 | PubTator, text mining | PubMed |
| Assessing the epithelial-to-mesenchymal plasticity in a small cell lung carcinoma (SCLC) and lung fibroblasts co-culture model. | Front Mol Biosci | 2023 | 36936987 | PubTator, text mining | PubMed |
| DNA methylation differences in monozygotic twins with Van der Woude syndrome. | Front Dent Med | 2023 | 36936396 | PubTator, text mining | PubMed |
| Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies. | Nat Commun | 2023 | 36932114 | PubTator, text mining | PubMed |
| Interaction network of extracellular vesicles building universal analysis via eye tears: iNEBULA. | Sci Adv | 2023 | 36921051 | PubTator, text mining | PubMed |
| Comprehensive isolation of extracellular vesicles and nanoparticles. | Nat Protoc | 2023 | 36914899 | PubTator, text mining | PubMed |
| Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma. | Cell Discov | 2023 | 36914617 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7045/papers?page=27